CIK: 0002043476 · Show all filings
Period: Q4 2024 (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $163,598 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INVESCO QQQ TR | 110,000 | $56,235 | 34.4% | $511.23 | — | PUT | 46090E953 |
| ADMA | ADMA BIOLOGICS INC | 2,287,542 | $39,231 | 24.0% | $18.81 | 0.0% | COM | 000899104 |
| INSM | INSMED INC | 350,000 | $24,164 | 14.8% | $72.02 | 0.0% | COM PAR $.01 | 457669307 |
| ZLAB | ZAI LAB LTD | 400,000 | $10,476 | 6.4% | $26.19 | — | ADR | 98887Q104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 992,000 | $7,341 | 4.5% | $9.27 | 0.0% | COM | 462260100 |
| — | AKERO THERAPEUTICS INC | 260,000 | $7,233 | 4.4% | $27.82 | — | COM | 00973Y108 |
| CLLS | CELLECTIS S A | 3,081,501 | $5,547 | 3.4% | $1.80 | — | SPON ADS | 15117K103 |
| AURA | AURA BIOSCIENCES INC | 472,576 | $3,885 | 2.4% | $9.41 | 0.0% | COM | 05153U107 |
| SGHT | SIGHT SCIENCES INC | 629,370 | $2,291 | 1.4% | $4.55 | 0.0% | COM | 82657M105 |
| TSHA | TAYSHA GENE THERAPIES INC | 965,556 | $1,670 | 1.0% | $2.07 | 0.0% | COM SHS | 877619106 |
| — | ULTRAGENYX PHARMACEUTICAL IN | 29,500 | $1,241 | 0.8% | $42.07 | — | CALL | 90400D908 |
| SYRE | SPYRE THERAPEUTICS INC | 50,000 | $1,164 | 0.7% | $29.32 | 0.0% | COM NEW | 00773J202 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 50,651 | $799 | 0.5% | $16.10 | 0.0% | COM NEW | 045396207 |
| APGE | APOGEE THERAPEUTICS INC | 15,000 | $680 | 0.4% | $51.00 | 0.0% | COM | 03770N101 |
| — | CORVUS PHARMACEUTICALS INC | 100,000 | $535 | 0.3% | $5.35 | — | PUT | 221015950 |
| BNTX | BIONTECH SE | 3,500 | $399 | 0.2% | $113.95 | — | SPONSORED ADS | 09075V102 |
| ORKA | ORUKA THERAPEUTICS INC | 20,000 | $388 | 0.2% | $24.40 | 0.0% | COM | 687604108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 7,596 | $320 | 0.2% | $49.61 | 0.0% | COM | 90400D108 |